Study population We included all patients registered as having type 2 diabetes in the National Diabetes Register who filled their first prescription for a GLP-1 receptor agonist, and, in a separate cohort, all patients registered as having type 2 diabetes in the National Diabetes Register who filled their first prescription for an SGLT2 inhibitor, between 1 January 2017 and 31 December 2021 (ensuring a minimum of 1-year follow-up until the end of the study period on 31 December 2022)
Statistical analysis was performed ANOVA (to analyse the difference between the means of more than two groups) or Students t test (to compare the means of specifically two groups), after normality was assessed by a Shapiro-Wilk test
However, GLP-1s may affect levothyroxine absorption, while weight loss itself can change how much thyroid medication you need
Its lightweight, non-greasy texture ensures quick absorption, making it suitable for all skin types
10.1016/j.sajb.2007.03.006 116 NiehlA.LacommeC.ErbanA.KopkaJ.KrmerU.FisahnJ
For oral appliances, your bite might feel different initially